Serveur d'exploration Tocilizumab - Merge (Accueil)

Index « ISSN » - entrée « Clin Rheumatol »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Clin Exp Nephrol < Clin Rheumatol < Clin. Exper.Med.  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 57.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
002907 (2013) P. I. Novikov [Russie] ; I. O. Smitienko [Russie] ; S. V. Moiseev [Russie]Tumor necrosis factor alpha inhibitors in patients with Takayasu's arteritis refractory to standard immunosuppressive treatment: cases series and review of the literature
002915 (2013) Paweł Kawalec [Pologne] ; Alicja Mikrut [Pologne] ; Natalia Wi Niewska [Pologne] ; Andrzej Pilc [Pologne]The effectiveness of tofacitinib, a novel Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic review and meta-analysis
002A82 (2013) Diogo Mendes [Portugal] ; Carlos Alves [Portugal] ; Francisco Batel Marques [Portugal]Safety of biologics approved for treating rheumatoid arthritis: analysis of spontaneous reports of adverse events
002C30 (2013) Aman Sharma [Inde] ; Karthik Gnanapandithan [États-Unis] ; Kusum Sharma [Inde] ; Susmita Sharma [Inde]Relapsing polychondritis: a review
002C32 (2013) Naoshi Nishina [Japon] ; Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Masataka Kuwana [Japon] ; Tsutomu Takeuchi [Japon]Reduction of plasma IL-6 but not TNF-α by methotrexate in patients with early rheumatoid arthritis: a potential biomarker for radiographic progression
002C46 (2013) Mislav Radic [Croatie] ; Dusanka Martinovic Kaliterna [Croatie] ; Josipa Radic [Croatie]Overview of vasculitis and vasculopathy in rheumatoid arthritis—something to think about
002D53 (2013) Jörg Kaufmann [Allemagne] ; Eugen Feist [Allemagne] ; Anne-Eve Roske [Allemagne] ; Wolfgang A. Schmidt [Allemagne]Monotherapy with tocilizumab or TNF-alpha inhibitors in patients with rheumatoid arthritis: efficacy, treatment satisfaction, and persistence in routine clinical practice
002D66 (2013) Yuya Takakubo [Japon, Finlande] ; Yasunobu Tamaki [Japon] ; Tomoyuki Hirayama [Japon] ; Kiyoshi Iwazaki [Japon] ; Kan Sasaki [Japon] ; Akiko Sasaki [Japon] ; Hiroharu Ohki [Japon] ; Noe Takakubo [Finlande, Japon] ; Yrjö T. Konttinen [Finlande] ; Michiaki Takagi [Japon]Inflammatory immune cell responses and Toll-like receptor expression in synovial tissues in rheumatoid arthritis patients treated with biologics or DMARDs
002D69 (2013) Vladimir Ognenovski [États-Unis] ; Marija Arsovska-Nalbanti [Macédoine (pays)] ; Dragan Chichikj [Macédoine (pays)] ; Jordan Calovski [Macédoine (pays)]Improving rheumatologic care and education in the Republic of Macedonia: model for rheumatologic education and care in a developing country—ILAR Initiative
002D70 (2013) Christoph Fiehn [Allemagne] ; Elisabeth Belke-Voss [Allemagne] ; Dietmar Krause [Allemagne] ; Siegfried Wassenberg [Allemagne] ; Rolf Rau [Allemagne]Improved radiological outcome of rheumatoid arthritis: the importance of early treatment with methotrexate in the era of biological drugs
002F50 (2013) Christian Gissel [Allemagne] ; Holger Repp [Allemagne]Cost per responder of TNF-α therapies in Germany
002F54 (2013) Goohyeon Hong [Corée du Sud] ; Hojoong Kim [Corée du Sud, États-Unis]Clinical characteristics and treatment outcomes of patients with relapsing polychondritis with airway involvement
002F67 (2013) Rafael Mendonça Da Silva Chakr [Brésil] ; José Alexandre Mendonça [Brésil] ; Claiton Viegas Brenol [Brésil] ; Ricardo Machado Xavier [Brésil] ; João Carlos Tavares Brenol [Brésil]Assessing rheumatoid arthritis disease activity with ultrasound
002F78 (2013) Pavel Horák [République tchèque] ; Martina Skácelová [République tchèque] ; Karel Hejduk [République tchèque] ; Andrea Smržová [République tchèque] ; Karel Pavelka [République tchèque]Abatacept and its use in the treatment of rheumatoid arthritis (RA) in the Czech Republic—data from the ATTRA registry
002F80 (2013) Girish ModyAFLAR & SARAA CONGRESS 2013
003616 (2012) Emilio Besada [Norvège] ; Johannes C. Nossent [Norvège]Ultrasonographic resolution of the vessel wall oedema with modest clinical improvement in a large-vessel vasculitis patient treated with tocilizumab
003623 (2012) Hubert De Boysson [France] ; Jérome Février [France] ; Amélie Nicolle [France] ; Christophe Auzary [France] ; Loïk Geffray [France]Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence
003632 (2012) Adel Alawadhi [Koweït] ; Khaldoon Alawneh [Jordanie] ; Zeyad Ahmed Alzahrani [Arabie saoudite]The effect of neutralizing antibodies on the sustainable efficacy of biologic therapies: what’s in it for African and Middle Eastern rheumatologists
003637 (2012) Yasuhiko Hirabayashi [Japon] ; Tomonori Ishii [Japon]The DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab
003643 (2012) Bassel El Zorkany [Égypte] ; Humaid A. Alwahshi [Oman] ; Mohamed Hammoudeh [Qatar] ; Samar Al Emadi [Qatar] ; Romela Benitha [Afrique du Sud] ; Adel Al Awadhi [Koweït] ; Elyes Bouajina [Tunisie] ; Ahmed Laatar [Tunisie] ; Samir El Badawy [Égypte] ; Marzooq Al Badi [Arabie saoudite] ; Mustafa Al-Maini [Émirats arabes unis] ; Jamal Al Saleh [Émirats arabes unis] ; Ramiz Alswailem [Arabie saoudite] ; Mahmood Moosa Tar Mahomed Ally [Afrique du Sud] ; Wafaa Batha ; Hachemi Djoudi [Algérie] ; Ayman El Garf [Égypte] ; Khaled El Hadidi [Égypte] ; Mohamed El Marzouqi [Émirats arabes unis] ; Musa Hadidi [Jordanie] ; Ajesh Basantharan Maharaj [Afrique du Sud] ; Abdel Fattah Masri [Liban] ; Ayman Mofti [Émirats arabes unis] ; Ibrahim Nahar [Koweït] ; Clive Allan Pettipher [Afrique du Sud] ; Catherine Elizabeth Spargo [Afrique du Sud] ; Paul Emery [Royaume-Uni]Suboptimal management of rheumatoid arthritis in the Middle East and Africa: could the EULAR recommendations be the start of a solution?
003684 (2012) A. Finet [France] ; M. Amini-Adle [France] ; B. Balme [France] ; F. Colson [France] ; L. Thomas [France]Nodular progression of lentigo malignant melanoma during a treatment with tocilizumab: cause or coincidence?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/ISSN.i -k "Clin Rheumatol" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/ISSN.i  \
                -Sk "Clin Rheumatol" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Merge
   |type=    indexItem
   |index=    ISSN.i
   |clé=    Clin Rheumatol
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021